University of Birmingham Endowment

Chromatwist is a provider of fluorescent probes for imaging applications and next generation fluorescent compounds.

Linear Diagnostics Limited is a diagnostics company based in Birmingham, United Kingdom, that specializes in developing a novel diagnostic platform technology leveraging linear dichroism (LD). Founded in 2011, the company focuses on a wide range of applications, including the detection of antibiotic resistance in infections and the identification of bacteria responsible for crop spoilage. The platform enables simultaneous measurement of multiple targets from a single sample and utilizes various molecular recognition methods to enhance detection capabilities. Additionally, Linear Diagnostics offers a handheld reader for measuring linear dichroism signals, providing a streamlined and efficient approach to molecular diagnostics. The technology represents a significant advancement over existing methods, facilitating quicker and more accurate testing processes.

Tyseley Energy Park develops an Energy Innovation Zone (EIZ) to help Tyseley and Birmingham overcome the severe energy business and social challenges it currently faces. The TEP EIZ reduces emissions and stimulates growth and will integrate low carbon technologies and infrastructure needed to support new approaches to clean energy.

Smart Antenna Technologies Ltd specializes in designing and developing advanced smart antenna systems for the mobile device and infrastructure markets. The company offers innovative, multi-band, multi-functional, and multi-port antenna solutions that cater to a range of applications including smartphones, laptops, tablets, small cells, Internet of Things devices, and automotive systems. Founded in 2013 as a spinout from the University of Birmingham, Smart Antenna Technologies has patented a pioneering technology that significantly reduces the number of antennas needed in devices, replacing multiple existing antennas with a single, compact unit. This technology not only decreases manufacturing costs and the physical size of devices but also enhances performance and battery life. The company serves a diverse clientele, including handset manufacturers across the United States, Europe, South Korea, Japan, and China, addressing the increasing demand for efficient antenna solutions suitable for next-generation cellular technologies like 4G LTE. With its headquarters in Birmingham and an additional office in Bath, the company continues to drive innovation in antenna design.

Cytox Limited is focused on developing products and services aimed at addressing neurodegenerative disorders, particularly Alzheimer's disease (AD). The company specializes in cellular and genetic assays that facilitate the diagnosis and treatment of AD, leveraging the cell division cycle theory of its pathogenesis. It has created a genetic-based blood test designed for early-stage risk assessment and diagnosis of Alzheimer's disease. Cytox also offers biomarker and drug-screening services to pharmaceutical companies engaged in clinical trials for AD and mild cognitive impairment treatments. By collaborating with Affymetrix, a part of Thermo Fisher Scientific, Cytox supports the development of novel therapeutics aimed at combating this growing condition, which currently affects millions worldwide. Founded in 2004 and headquartered in Birmingham, UK, with additional offices in Manchester and Oxford, Cytox serves a global clientele that includes pharmaceutical and biotechnology firms, as well as research laboratories.